Growing Pains

Growing pains in dogs, medically known as panosteitis, is a self-limiting inflammatory condition that affects the long bones of young, rapidly growing dogs. The condition is characterized by the spontaneous onset of pain and lameness that typically shifts from one limb to another over the course of the disease. While the name "growing pains" suggests a benign and minor ailment, panosteitis can cause significant discomfort and distress in affected dogs, sometimes producing severe lameness that prevents the dog from bearing weight on the affected limb.

The condition primarily affects dogs between five and eighteen months of age, coinciding with the period of most rapid skeletal growth. Large and giant breed dogs are disproportionately affected, with German Shepherds being the breed most commonly diagnosed with panosteitis. The disease involves inflammation within the medullary cavity and endosteal surfaces of the long bones, where new bone formation and remodeling are occurring at an accelerated rate during growth. The inflammatory process causes pressure within the bone, producing the characteristic deep pain that affected dogs experience.

Panosteitis was first described in the veterinary literature in the 1950s and has since been recognized as one of the most common causes of lameness in young large-breed dogs. Despite decades of study, the exact cause of panosteitis remains incompletely understood, which is reflected in the variety of names the condition has been given over the years, including eosinophilic panosteitis, enostosis, and juvenile osteomyelitis. The term growing pains, while not technically precise, has become widely used by veterinarians and dog owners alike because it effectively communicates the age-related and self-limiting nature of the condition.

The good news for owners of dogs diagnosed with panosteitis is that the condition is universally self-limiting, meaning it will resolve on its own as the dog matures and skeletal growth slows. Most dogs outgrow the condition by two years of age, and many experience resolution by 18 months. While the disease runs its course, management focuses on controlling pain and maintaining the dog's comfort and quality of life.

The precise cause of panosteitis has not been definitively established, despite extensive investigation over many decades. Several theories have been proposed and studied, and it is likely that the condition results from a combination of factors rather than a single causative agent. The most widely accepted current understanding is that panosteitis represents a disturbance in the normal process of intramedullary bone formation and remodeling that occurs during rapid skeletal growth in young dogs.

One prominent theory implicates disruptions in the vascular supply to the bone marrow and endosteal surfaces of the long bones. During rapid growth, the blood supply within the bone must continuously adapt to support new bone formation, and localized areas of vascular insufficiency may lead to focal regions of bone marrow necrosis and subsequent inflammatory response. The resulting edema and new bone formation within the medullary cavity increases intraosseous pressure, causing the pain that characterizes the condition. This vascular theory is supported by the histological findings of medullary fibrosis and new bone formation observed in affected bones.

Nutritional factors, particularly high-calorie and high-protein diets, have been associated with an increased incidence of panosteitis in susceptible breeds. Diets that promote excessively rapid growth rates may place additional stress on the developing skeletal system and predispose dogs to various developmental orthopedic conditions, including panosteitis. Overfeeding and ad libitum feeding of energy-dense puppy diets to large-breed puppies have been identified as risk factors, and controlled feeding of appropriately formulated large-breed puppy diets is recommended as a preventive measure.

Genetic predisposition clearly plays a role in panosteitis susceptibility, as evidenced by the strong breed predilection. German Shepherds have a particularly high incidence of the condition, and familial patterns of occurrence have been documented within the breed. The genetic basis likely involves multiple genes that influence the rate and pattern of skeletal growth, bone metabolism, and potentially immune regulation. Male dogs are affected more frequently than females, with some studies reporting a male-to-female ratio of approximately four to one, suggesting a hormonal influence on disease susceptibility.

The hallmark symptom of panosteitis is lameness that appears suddenly, often without any history of trauma or injury. The onset can be quite dramatic, with an apparently healthy young dog becoming acutely lame seemingly overnight. The lameness can range from a mild limp to complete inability to bear weight on the affected limb. Dogs with panosteitis typically exhibit a weight-shifting lameness, favoring the affected limb and altering their gait to minimize pressure on the painful bone. The lameness may be most pronounced after periods of rest and may improve somewhat with gentle activity, only to worsen again after vigorous exercise.

One of the most distinctive features of panosteitis is the shifting or migrating nature of the lameness. The pain may initially affect one forelimb, then apparently resolve in that limb only to appear in a hindlimb or the opposite forelimb days to weeks later. This shifting pattern can be confusing and alarming for owners, who may wonder why their dog's lameness keeps moving from one leg to another. In some cases, multiple limbs may be affected simultaneously, producing a generalized stiffness and reluctance to move that can be particularly distressing to observe.

Pain on deep palpation of the affected long bones is the most consistent and diagnostically useful physical examination finding. When a veterinarian applies firm pressure along the shaft of the affected bone, particularly the diaphysis (mid-shaft region), the dog typically exhibits a pain response that may include flinching, pulling the limb away, vocalizing, or turning to look at or mouth the area being palpated. This deep bone pain distinguishes panosteitis from joint-related conditions, where the pain is typically localized to the joint itself and elicited by joint flexion, extension, or manipulation.

Systemic signs may accompany the musculoskeletal symptoms in some dogs, particularly during acute episodes. These can include decreased appetite, lethargy, mild fever, and a general malaise that goes beyond what would be expected from limb pain alone. Weight loss may occur in dogs with prolonged episodes due to reduced appetite and increased metabolic demands from the inflammatory process. Muscle atrophy of the affected limb may develop if the lameness is severe and prolonged, as the dog avoids using the painful limb. Most owners report that their dog's personality and energy level are diminished during active episodes, with improvement noted during pain-free intervals.

The diagnosis of panosteitis is typically straightforward when classic clinical findings are present in a young, large-breed dog. The combination of shifting leg lameness, pain on deep palpation of long bones, and the appropriate signalment strongly suggests panosteitis. However, diagnostic imaging is important both to confirm the clinical suspicion and to rule out other potentially more serious conditions that can cause similar signs in young dogs, such as hypertrophic osteodystrophy, osteochondrosis, bone infections, and bone tumors.

Radiography is the primary imaging modality used to diagnose panosteitis and is usually sufficient for definitive diagnosis. The characteristic radiographic finding is an increased medullary density within the affected long bone, appearing as a hazy or patchy opacification of the medullary cavity that is most commonly centered in the diaphyseal region. This increased density represents the inflammatory edema, fibrosis, and new endosteal bone formation occurring within the medullary canal. In early cases, the radiographic changes may be subtle and easily overlooked, while in more advanced cases, the increased medullary density is readily apparent.

It is important to note that radiographic changes may lag behind clinical signs by several days. A dog that is acutely lame on a particular limb may have normal-appearing radiographs if the images are obtained very early in the course of an episode. If panosteitis is strongly suspected based on clinical findings but radiographs appear normal, repeat imaging in seven to fourteen days often reveals the characteristic changes. Conversely, radiographic evidence of panosteitis may persist for weeks to months after clinical signs in that particular bone have resolved, as the remodeling process takes time to normalize the medullary appearance.

Additional radiographic features that may be observed include roughening or thickening of the endosteal surface of the cortex, periosteal new bone formation along the shaft of the affected bone, and subtle cortical thickening. These changes reflect the reactive bone formation that occurs in response to the intramedullary inflammatory process. When multiple limbs are affected, radiographs of all four limbs may reveal various stages of the disease simultaneously, with some bones showing active changes and others showing evidence of previous episodes that are in various stages of resolution.

Since panosteitis is a self-limiting condition that resolves spontaneously as the dog matures, treatment is focused entirely on managing pain and maintaining the dog's comfort and quality of life during episodes of active disease. There is no treatment that shortens the duration of the condition or prevents its recurrence, but effective pain management can dramatically improve the affected dog's well-being during what can be a prolonged and uncomfortable disease course.

Nonsteroidal anti-inflammatory drugs are the primary pharmacological treatment for panosteitis and are typically very effective at controlling the pain and inflammation associated with the condition. Commonly used medications include carprofen, meloxicam, and deracoxib, which are veterinary-approved NSAIDs that provide both analgesic and anti-inflammatory effects. These medications are generally administered during active episodes and may be discontinued during pain-free intervals to minimize the duration of drug exposure. The response to NSAID therapy is usually good, with most dogs showing significant improvement in comfort and mobility within one to two days of initiating treatment.

In cases where NSAIDs alone do not provide adequate pain relief, additional analgesic strategies may be employed. Gabapentin, an anticonvulsant medication with analgesic properties, can be added to the treatment regimen to address the neuropathic component of bone pain. Tramadol, an opioid-like analgesic, may be used in the short term for severe pain episodes. Acetaminophen, when used under veterinary supervision and at appropriate canine doses, can provide supplemental analgesia. In rare cases of exceptionally severe pain, stronger opioid medications may be warranted for brief periods.

Activity modification is an important component of managing panosteitis. During acute episodes, dogs should have their exercise restricted to short, gentle leash walks for elimination purposes and brief periods of mild activity. High-impact activities such as running, jumping, rough play with other dogs, and stair climbing should be avoided during periods of active lameness. However, complete strict rest is generally not recommended, as gentle movement helps maintain muscle mass, joint mobility, and the dog's mental well-being. As the lameness improves, activity can be gradually increased, with the understanding that temporary setbacks may occur.

Panosteitis demonstrates a strong breed predilection that primarily encompasses large and giant breed dogs, with certain breeds being particularly overrepresented in clinical case series. Understanding which breeds are at highest risk helps owners and veterinarians maintain a high index of suspicion for the condition and facilitates early diagnosis and appropriate management.

The German Shepherd is by far the breed most commonly affected by panosteitis, and the condition is sometimes colloquially referred to as "German Shepherd growing pains" due to this strong association. Studies have shown that German Shepherds account for a disproportionately large percentage of panosteitis cases relative to their representation in the general dog population. Within the breed, male German Shepherds appear to be affected more frequently than females, consistent with the overall male predominance observed across all breeds. The high incidence in German Shepherds likely reflects a combination of breed-specific genetic factors and the breed's characteristically rapid growth rate.

Golden Retrievers and Labrador Retrievers are also frequently diagnosed with panosteitis, which is not surprising given their large size, rapid growth rates, and overall popularity as pet breeds. Rottweilers, Doberman Pinschers, and Great Danes represent additional large and giant breeds with recognized susceptibility to the condition. The giant breeds, including Great Danes, Irish Wolfhounds, and Saint Bernards, may experience particularly prolonged courses of panosteitis due to their extended growth periods, as these breeds continue to grow and mature for a longer time than standard large breeds.

Basset Hounds represent an interesting exception to the typical large-breed predilection, as they are a medium-sized breed with disproportionately short legs that nonetheless has a recognized predisposition to panosteitis. Their inclusion among affected breeds suggests that the rate of bone growth and remodeling, rather than absolute body size alone, may be the more relevant risk factor. Other breeds that have been reported to develop panosteitis include the German Shorthaired Pointer, Weimaraner, Boxer, Mastiff breeds, Bernese Mountain Dog, and various mixed-breed dogs of large body type. While panosteitis is overwhelmingly a disease of large breeds, rare cases in medium and small breed dogs have been documented.

Nutrition plays an important role in both the prevention and management of panosteitis, and appropriate dietary choices during the critical growth period can help reduce the risk and severity of the condition in susceptible breeds. The relationship between diet and developmental orthopedic diseases in large-breed puppies has been extensively studied, and clear evidence links excessive caloric intake and overly rapid growth rates with an increased incidence of conditions including panosteitis, hypertrophic osteodystrophy, and osteochondrosis.

Feeding a diet specifically formulated for large-breed puppies is one of the most important preventive measures that owners of at-risk breeds can take. These diets are designed to promote steady, controlled growth rather than the maximal growth rates that can result from feeding standard puppy diets or adult dog food supplemented with additional calories. Large-breed puppy formulas typically have a moderate calorie density, controlled levels of calcium and phosphorus, and an appropriate calcium-to-phosphorus ratio that supports healthy skeletal development without promoting excessive growth velocity.

Meal feeding rather than free-choice (ad libitum) feeding is strongly recommended for large-breed puppies to prevent overconsumption and excessively rapid weight gain. Puppies that are allowed unlimited access to food tend to consume more calories than they need, leading to faster growth rates and greater stress on the developing skeletal system. Dividing the daily food allotment into two or three measured meals allows the owner to control caloric intake precisely and adjust the amount fed based on the puppy's body condition and growth trajectory. Regular body condition assessments, either at home or during veterinary visits, help ensure that the puppy maintains an ideal lean body condition.

Calcium supplementation should be strictly avoided in large-breed puppies eating a complete and balanced commercial diet, as excess dietary calcium can disrupt normal bone remodeling processes and increase the risk of developmental orthopedic conditions. Well-formulated commercial puppy foods contain all the calcium and other minerals needed for healthy skeletal growth, and adding calcium supplements, bone meal, or calcium-rich human foods to an already balanced diet can create dangerous mineral imbalances. Owners who prepare homemade diets for large-breed puppies should work closely with a veterinary nutritionist to ensure that mineral levels are appropriate and properly balanced.

Several other conditions can cause lameness and bone pain in young dogs, making it important to consider and rule out these differential diagnoses before attributing a dog's symptoms to panosteitis. While the clinical presentation of panosteitis is often characteristic, some overlap exists with other developmental orthopedic diseases and more serious pathological conditions that require different treatment approaches.

Hypertrophic osteodystrophy is another developmental bone condition that affects young, rapidly growing large-breed dogs and can produce symptoms that overlap with panosteitis. However, hypertrophic osteodystrophy typically affects the metaphyseal regions of the long bones near the growth plates rather than the diaphyseal region affected in panosteitis, and the radiographic changes are distinctly different. Dogs with hypertrophic osteodystrophy often present with more pronounced systemic illness, including high fever, severe lethargy, and swelling around the affected growth plates. The condition can be significantly more severe than panosteitis and in some cases can be life-threatening.

Osteochondrosis and osteochondritis dissecans are developmental joint conditions that cause lameness in young, large-breed dogs but are distinguished from panosteitis by their localization to specific joints rather than the long bone shafts. The shoulder, elbow, stifle, and hock are the most commonly affected joints. Pain associated with osteochondrosis is elicited by joint manipulation rather than deep palpation of the bone shaft, and radiographic changes are localized to the articular surfaces within the joint. Elbow dysplasia, which encompasses several developmental abnormalities of the elbow joint including fragmented coronoid process and ununited anconeal process, is another common cause of forelimb lameness in young large-breed dogs.

While rare in young dogs, bone tumors such as osteosarcoma must be considered in the differential diagnosis, particularly in cases where the lameness is persistent and non-shifting. Osteosarcoma typically affects older dogs but can occasionally occur in young adults. The radiographic appearance of osteosarcoma, with its aggressive bone lysis and periosteal reaction, is usually distinctly different from the benign increased medullary density of panosteitis, but early or atypical cases may warrant additional diagnostics including fine-needle aspiration or biopsy. Infectious osteomyelitis, whether bacterial or fungal, can also produce bone pain and radiographic changes in young dogs and should be considered, particularly in dogs with systemic signs of infection or a history of penetrating wounds.

Managing a young dog through the period of panosteitis requires patience, understanding, and a commitment to providing supportive care that maximizes the dog's comfort during what can be a frustrating and emotionally challenging time for both the dog and the owner. The episodic and shifting nature of the condition means that periods of apparent recovery are often followed by recurrences, which can be disheartening for owners who believe their dog has finally overcome the problem.

Establishing realistic expectations is one of the most important aspects of living with a dog experiencing growing pains. Owners should understand that panosteitis typically follows a waxing and waning course over a period of several months, with individual episodes lasting one to several weeks. The shifting nature of the lameness means that as one limb improves, another may become affected, creating the impression that the dog is not getting better even when the overall trajectory is toward resolution. Most dogs experience their last episode of panosteitis by 18 to 24 months of age, though giant breeds may continue to have episodes somewhat longer.

Providing a comfortable environment for the affected dog involves several practical considerations. Soft, supportive bedding helps cushion painful limbs and encourages the dog to rest. Placing food and water bowls at an accessible height reduces the need for the dog to bend down, which can be uncomfortable when forelimbs are affected. Ramps can be provided for dogs that need to access furniture or vehicles to eliminate the need for jumping. Non-slip surfaces such as rugs or yoga mats on hardwood or tile floors help prevent painful slips and falls that can worsen the dog's discomfort and anxiety about moving.

Maintaining the young dog's socialization and mental stimulation during episodes of panosteitis is important for their behavioral development and emotional well-being. While physical activity may need to be restricted during acute episodes, mental enrichment activities such as puzzle feeders, scent games, basic obedience training using gentle methods, and calm social interactions can help prevent boredom and frustration. As the puppy enters pain-free intervals, gradually resuming age-appropriate physical activities and social experiences helps ensure that the dog continues to develop normal behavioral patterns and confidence despite the intermittent limitations imposed by the condition.

The long-term outlook for dogs diagnosed with panosteitis is excellent, as the condition resolves completely in virtually all affected dogs once skeletal maturity is reached. Unlike many orthopedic conditions that can leave lasting structural damage or predispose to chronic degenerative joint disease, panosteitis does not cause permanent bone damage or long-term musculoskeletal complications. The inflammatory process within the bone resolves fully, and the affected bones remodel to their normal architecture and density without residual abnormalities.

The timeline for complete resolution varies among individual dogs and is influenced by the breed, the rate of skeletal maturation, and the pattern of episodes. Most dogs experience their final episode of panosteitis between 12 and 24 months of age. German Shepherds, the most commonly affected breed, typically resolve by 18 months. Giant breed dogs that have extended growth periods may continue to experience occasional episodes up to approximately 24 months of age. Once the last episode resolves, recurrence is extremely rare, and the dog can be expected to lead a normal, active life without any ongoing consequences from the condition.

During the recovery period following the last episode, dogs can gradually return to full activity levels. Muscle mass that may have been lost during periods of reduced activity will rebuild naturally as the dog resumes normal exercise. Joint range of motion, which is not directly affected by panosteitis, should be normal throughout and after the disease course. Dogs that experienced panosteitis during puppyhood grow into adults with no increased risk of arthritis, bone disease, or other musculoskeletal conditions as a result of their earlier growing pains.

For breeders of susceptible breeds, it is worth noting that while panosteitis is uncomfortable for the affected dog, it does not represent a serious hereditary defect that would necessarily warrant removing an affected individual from a breeding program, provided other health screenings are satisfactory. However, if panosteitis is occurring with unusually high frequency within a particular breeding line, this pattern may warrant evaluation of the genetic and nutritional factors that could be contributing to the increased incidence. Responsible breeding practices that consider the overall health profile of individual dogs and their relatives remain the best approach to managing breed-specific health concerns.